Previous 10 | Next 10 |
The following slide deck was published by Dynavax Technologies Corporation in conjunction with their 2022 Q3 earnings call. For further details see: Dynavax Technologies Corporation 2022 Q3 - Results - Earnings Call Presentation
Dynavax press release ( NASDAQ: DVAX ): Q3 GAAP EPS of $0.43 beats by $0.10 . Revenue of $167.74M (+54.9% Y/Y) beats by $8.33M . HEPLISAV-B® vaccine net product revenue of $37.5 million, up 65% from $22.7 million for Q3 2021 CpG 101...
Dynavax Reports Third Quarter 2022 Financial Results PR Newswire Q3 2022 total revenue of $167.7 million , up 55% from $108.3 million for Q3 2021 HEPLISAV-B ® vaccine net product revenue of $37.5 million, up 65% from ...
Dynavax to Report Third Quarter Financial Results and Host Conference Call on November 3, 2022 PR Newswire EMERYVILLE, Calif. , Oct. 20, 2022 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips My task today is to find seven of the most undervalued long-term stocks to buy now. We need to determine two things before stock selection takes place. First, it’s important to define what is meant by long-term. Se...
Dynavax to Present at the H.C. Wainwright 3rd Annual Hepatitis B Virus Virtual Conference PR Newswire EMERYVILLE, Calif. , Oct. 14, 2022 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company deve...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips If under-the-radar small-cap stocks are your jam, I’ve got three selections from the S&P SmallCap 600 that might be right up your alley. The small-cap index is down 20.3% year to date. That’s 460 ba...
A positive analyst take on Dynavax Technologies ' (NASDAQ: DVAX) stock lit the biotech company's shares on fire Tuesday. While many other stocks traded down on the day, Dynavax soared more than 5% higher on the back of that bullish review. The enthusiastic analyst is JMP Securit...
Summary Pharmaceuticals/biotechnology and healthcare providers are undervalued relative to 11-year averages. Healthcare equipment is the most overpriced subsector. Fast facts on IYH, an alternative to XLV. 10 stock cheaper than their peers in September. This mont...
Clover Biopharmaceuticals said its contract development and manufacturing organization (CDMO) received a European Union Good Manufacturing Practice (EU GMP) certificate for producing the company's lead COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum). Clover created the ...
News, Short Squeeze, Breakout and More Instantly...
Dynavax Technologies Corporation Company Name:
DVAX Stock Symbol:
NASDAQ Market:
Dynavax Technologies Corporation Website:
Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024 PR Newswire EMERYVILLE, Calif. , July 23, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company dev...
Dynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program PR Newswire EMERYVILLE, Calif. , June 27, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing inn...
2024-06-21 02:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...